FCS and its MSO, Core Ventures, have leveraged partnerships in a unified approach to create a solution to remain operational in the wake of the Change Healthcare shutdown in February 2024.
FCS has opened a new state-of-the-art facility at 2824 Enterprise Road, Orange City, FL 32763-8428 to provide comprehensive treatments and a variety of services to adults with cancer, blood disorders and other diseases.
FCS continues to advance the treatment of gastrointestinal and genitourinary cancers, as evidenced by participation at two global gatherings held this month and sponsored by the American Society of Clinical Oncology (ASCO®).
A best practices program developed at Florida Cancer Specialists & Research Institute (FCS) has been shown to improve outcomes for adult patients prescribed selinexor for the treatment of relapsed/refractory multiple myeloma (RRMM).
Senior Vice President & Data Officer Trevor Heritage, PhD will share learnings gained from the statewide practice’s development of an innovative propriety precision oncology platform at the Precision Medicine World Conference (PMWC® 2024) being held this month in Santa Clara, California.
FCS in collaboration with AdventHealth Heart of Florida and Central Florida Cancer Institute, has been granted a three-year accreditation from the National Accreditation Program for Breast Centers (NAPBC), a quality program of the American College of Surgeons (ACS).
FCS is pleased to announce the appointments of Joel Grossman, MD and Maen Hussein, MD to its Executive Board. Dr. Hussein also serves on the Finance Committee.
FCS physicians shine as leading experts in medical oncology, gynecologic oncology, hematology and more across the many communities we serve in Florida.
The FCS 2022 Annual Report, produced by the FCS in-house Marketing team, has been recognized in the 4th Annual Healthcare Digital Marketing Awards, a prestigious national awards program that recognizes excellence in healthcare and medical marketing.
Research conducted at FCS will be among the cutting-edge advancements being shared at the American Society of Hematology.
Strategic Alliance Partnerships
Through our strategic alliance partnership with MJH Life Sciences®, FCS is part of a national network of leading oncology experts sharing the latest news in cancer research and best treatment practices to continuously improve the quality of life for our patients.